Meds & supplements › Mesna
Medicine
MESNEX is indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis.
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Limitation of Use: MESNEX is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia.
The following are discussed in more detail in other sections of the labeling.
MESNEX is contraindicated in patients known to be hypersensitive to MESNEX or to any of the excipients [ see Warnings and Precautions ].
No clinical drug interaction studies have been conducted with MESNEX.
sofidex [Internet]. Daloreum; c2026. Mesna; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/mesna
sofidex. (2026, August 3). Mesna. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/mesna
Mesna. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/mesna
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.